Thursday, October 9, 2025

CCI clears PNC Infratech’s acquisition of Jaiprakash Associates

Date:

The Competition Commission of India (CCI) has approved the proposed acquisition of debt-laden Jaiprakash Associates Limited (JAL) by PNC Infratech Limited.Under the deal, PNC Infratech will acquire at least 95% and up to 100% of JAL, either directly or through a special purpose vehicle that it may incorporate as a wholly owned subsidiary. JAL is currently undergoing corporate insolvency resolution under the Insolvency and Bankruptcy Code, 2016.PNC Infratech, a publicly listed infrastructure company, is primarily engaged in Engineering, Procurement and Construction (EPC) projects in the road and highway sector, including highways, expressways, bridges, flyovers, and airport runways.

JAL, on the other hand, is a diversified infrastructure and industrial group with interests in hydropower generation, cement manufacturing, real estate development, hospitality, and EPC contracting.JAL has been among India’s most high-profile debt-stressed companies, weighed down by loans exceeding ₹20,000 crore. Its cement and real estate assets have attracted multiple bidders in recent years as part of the insolvency process.The acquisition gives PNC Infratech an opportunity to diversify beyond roads and highways and gain a foothold in cement and power, sectors that could complement its EPC expertise.The CCI said a detailed order will be issued separately.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Developed nation status, $30-35 trillion economy by 2047 well within reach: Piyush Goyal

Commerce and Industry Minister Piyush Goyal on Wednesday said...

Thai central bank unexpectedly holds rates; trims growth forecast

Thailand's central bank left its key interest rate steady...

Tata Capital issues shares worth ₹4,642 crore to 68 anchor investors ahead of biggest IPO of 2025

IPO-bound Tata Capital has issued shares worth ₹4,642 crore...

Rubicon Research IPO: Pharma firm raises ₹619 crore from anchor investors ahead of public issue — Details here

रूबिकॉन रिसर्च आईपीओ: फार्मास्युटिकल कंपनी रूबिकॉन रिसर्च ने बुधवार,...